Abstract
INTRODUCTION
We aimed to investigate which factors affect plasma biomarker levels via amyloid beta (Aβ)-independent or Aβ-dependent effects and improve the predictive performance of these biomarkers for Aβ positivity on positron emission tomography (PET).
METHODS
A total of 2935 participants underwent blood sampling for measurements of plasma Aβ42/40 ratio, phosphorylated tau 217 (p-tau217; ALZpath), glial fibrillary acidic protein (GFAP), and neurofilament light chain (NfL) levels using single-molecule array and Aβ PET. Laboratory findings were collected using a routine blood test battery.
RESULTS
Aβ-independent factors included hemoglobin and estimated glomerular filtration rate (eGFR) for p-tau217 and hemoglobin, eGFR, and triiodothyronine (T3) for GFAP and NfL. Aβ-dependent factors included apolipoprotein E genotypes, body mass index status for Aβ42/40, p-tau217, GFAP, and NfL. However, these factors exhibited negligible or modest effects on Aβ positivity on PET.
DISCUSSION
Our findings highlight the importance of accurately interpreting plasma biomarkers for predicting Aβ uptake in real-world settings.
Highlights
We investigated factor–Alzheimer’s disease plasma biomarker associations in a large Korean cohort.
Hemoglobin and estimated glomerular filtration rate affect the biomarkers independently of brain amyloid beta (Aβ).
Apolipoprotein E genotypes and body mass index status affect the biomarkers dependent on brain Aβ.
Addition of Aβ-independent factors shows negligible effect in predicting Aβ positivity.
Adjusting for Aβ-dependent factors shows a modest effect in predicting Aβ positivity.
If you do not see content above, kindly GO TO SOURCE.
Not all publishers encode content in a way that enables republishing at Neuro.vip.
This post is Copyright: Eun Hye Lee,
Sung Hoon Kang,
Daeun Shin,
Young Ju Kim,
Henrik Zetterberg,
Kaj Blennow,
Fernando Gonzalez‐Ortiz,
Nicholas J. Ashton,
Bo Kyoung Cheon,
Heejin Yoo,
Hongki Ham,
Jihwan Yun,
Jun Pyo Kim,
Hee Jin Kim,
Duk L. Na,
Hyemin Jang,
Sang Won Seo,
the K‐ROAD study group | November 13, 2024